Información del producto
Nombre:CP-944629
Marca:Biosynth
Descripción:CP-944629 is an investigational drug that has been shown to have anticancer activity. The mechanism of action is currently unknown, but it has been speculated that this drug may act by inhibiting DNA methylation and/or altering the activity of microRNAs. CP-944629 is currently in Phase I clinical trials for the treatment of multiple myeloma and non-small cell lung carcinoma. It has also been shown to induce apoptosis in a number of cancer cells, including those derived from muscle tissue, leukemia, and breast cancer. CP-944629 has not yet been tested in combination with other treatments; however, it has been repurposed as a potential treatment for spinal muscular atrophy (SMA).
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:372.34 g/mol
Fórmula:C19H15F3N4O
Pureza:Min. 95%
Consulta técnica sobre: CP-944629
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.